Cargando…
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
OBJECTIVE: Fibrotic organ responses have recently been identified as long-term complications in diabetes. Indeed, insulin resistance and aberrant hepatic lipid accumulation represent driving features of progressive non-alcoholic fatty liver disease (NAFLD), ranging from simple steatosis and non-alco...
Autores principales: | Wolff, Gretchen, Sakurai, Minako, Mhamane, Amit, Troullinaki, Maria, Maida, Adriano, Deligiannis, Ioannis K., Yin, Kelvin, Weber, Peter, Morgenstern, Jakob, Wieder, Annika, Kwon, Yun, Sekar, Revathi, Zeigerer, Anja, Roden, Michael, Blüher, Matthias, Volk, Nadine, Poth, Tanja, Hackert, Thilo, Wiedmann, Lena, De Angelis Rigotti, Francesca, Rodriguez-Vita, Juan, Fischer, Andreas, Mukthavaram, Rajesh, Limphong, Pattraranee, Tachikawa, Kiyoshi, Karmali, Priya, Payne, Joseph, Chivukula, Padmanabh, Ekim-Üstünel, Bilgen, Martinez-Jimenez, Celia P., Szendrödi, Julia, Nawroth, Peter, Herzig, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034319/ https://www.ncbi.nlm.nih.gov/pubmed/35378329 http://dx.doi.org/10.1016/j.molmet.2022.101487 |
Ejemplares similares
-
TSC22D4 interacts with Akt1 to regulate glucose metabolism
por: Demir, Sevgican, et al.
Publicado: (2022) -
Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
por: Ekim Üstünel, Bilgen, et al.
Publicado: (2016) -
Emerging Targets in Type 2 Diabetes and Diabetic Complications
por: Demir, Sevgican, et al.
Publicado: (2021) -
Development of an mRNA replacement therapy for phenylketonuria
por: Perez-Garcia, Carlos G., et al.
Publicado: (2022) -
Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS
por: Hirunagi, Tomoki, et al.
Publicado: (2021)